Critical Care News and Research

RSS

Cipla launches generic Pirfenidone for IPF

Cipla, among the world's leading generic pharmaceutical companies, has introduced Pirfenidone in India under the brand name Pirfenex, for the treatment of IPF. A chronic progressive form of lung disease, IPF has average survival rates as low as 3-5 years which is less than many cancers. Till now there is no approved treatment for IPF.

20 Oct 2010

Elsevier / MC Strategies partners with AORN to develop latest module for Perioperative Collection

Elsevier / MC Strategies a pioneer in providing e-learning solutions to more than 1,300 healthcare organizations, has partnered with the Association of periOperative Registered Nurses (AORN) to develop the latest module for Mosby's Nursing Skills Perioperative Collection, the only perioperative-specific set of nursing skills approved by AORN to be consistent with the Standards and Recommended Practices.

20 Oct 2010

Beryl Institute awards $1,000 grants to health care organizations

As part of its commitment to supporting efforts to improve the patient experience in healthcare, The Beryl Institute has awarded $1,000 grants to ten health care organizations that are exploring effective methods for addressing patient experience issues.

20 Oct 2010

Study reveals sex hormones can influence structure and function of heart's right ventricle

In the largest human study to date on the topic, researchers have uncovered evidence of the possible influence of human sex hormones on the structure and function of the right ventricle (RV) of the heart.

20 Oct 2010

NHLBI launches multicenter study of body cooling treatment in infants and children after cardiac arrest

The National Heart, Lung, and Blood Institute (NHLBI), part of the National Institutes of Health, has launched the first large-scale, multicenter study to investigate the effectiveness of body cooling treatment in infants and children who have had cardiac arrest. The Therapeutic Hypothermia after Pediatric Cardiac Arrest (THAPCA) trials total more than $21 million over six years.

20 Oct 2010

Long term exposure to air pollution increases risk of severe COPD

Long term exposure to low-level air pollution may increase the risk of severe chronic obstructive pulmonary disease (COPD), according to researcher s in Denmark. While acute exposure of several days to high level air pollution was known to be a risk factor for exacerbation in pre-existing COPD, until now there had been no studies linking long-term air pollution exposure to the development or progression of the disease.

20 Oct 2010

Researchers explore impact of various factors on increasing rates of Clostridium difficile infection

In five different studies presented at the American College of Gastroenterology's (ACG) 75th Annual Scientific meeting in San Antonio, researchers explored the impact of various factors on increasing rates of Clostridium difficile infection (C. difficile), such as the use of proton pump inhibitors (PPIs) and the substantial increase in antibiotic use due to new National Hospital Quality Measures; strategies to combat high rates of C. difficile infections; and cutting‐edge treatments for this potentially deadly-and quite common-infection.

19 Oct 2010

OrSense's NBM 200MP non-invasive Hb measurement system more accurate than invasive POC devices

OrSense Ltd., developer of monitors for non-invasive measurements of various blood parameters, presented in an oral presentation at the American Society of Anesthesiologists (ASA) annual meeting in San Diego, results showing that hemoglobin (Hb) measurements obtained by its NBM 200MP, a non-invasive Hb measurement system, showed accurate performance during hemorrhage conditions compared with invasive point of care (POC) devices.

18 Oct 2010

Abreu btt 700 System for continuous temperature monitoring launched at ASA Annual Meeting

Conquering the last frontier for monitoring vital signs, Brain Tunnelgenix Technologies Corp. is introducing the Abreu btt™ 700 System for continuous temperature monitoring at the Annual Meeting of the American Society of Anesthesiologists (ASA) today. The Abreu btt 700 System sensor is approved by the U.S. Food and Drug Administration for placement on the skin and to be used during surgical procedures, recovery room, intensive care and general patient monitoring.

18 Oct 2010

Sirius collaborates with Golden Helix to advance diagnostic pipeline

Sirius Genomics, a developer of companion diagnostics, and Golden Helix, a global leader in genetic analysis solutions, announced today a collaboration under which Golden Helix will apply its expertise and technologies in SNP and copy number variant analysis and predictive modeling to advance development of Sirius' diagnostic pipeline.

13 Oct 2010

Archimedes publishes results from FPNS Phase III clinical study for breakthrough cancer pain

Archimedes Pharma, an emerging specialty pharma company focused on oncology, pain, neurology and critical care sectors, today announced publication of results from a Phase III, long-term safety, tolerability and consistency of effect, clinical study of fentanyl pectin nasal spray (FPNS) in the treatment of breakthrough cancer pain (BTCP).

13 Oct 2010

Florida Governor issues Proclamation recognizing outstanding work of Healthcare Quality Professionals

Florida Governor Charlie Crist issued a Proclamation recognizing the outstanding work Healthcare Quality Professionals do for the people of Florida. This proclamation mirrors the sentiments of National Healthcare Quality Week, October 17-23rd, which celebrates the work of Healthcare Quality Professionals in improving patient outcomes and healthcare delivery systems.

11 Oct 2010

IV ibuprofen effective in reducing fever in hospitalized patients

Cumberland Pharmaceuticals Inc. today announced the publication of data affirming the safety and efficacy of Caldolor (ibuprofen) Injection in treating fever in critically ill and non-critically ill adults. Published in the peer-reviewed journal Critical Care, the study showed that IV ibuprofen was significantly more effective at reducing fever in hospitalized patients than placebo.

8 Oct 2010

Royal Philips Electronics introduces IntelliVue MX800 patient monitoring system

Royal Philips Electronics today introduced the IntelliVue MX800 patient monitoring system, a new dimension in patient care that provides immediate access to comprehensive patient information directly at the monitor. In addition to displaying and recording traditional data such as patient vital signs, the IntelliVue MX800 offers direct access to patient information from almost any system on a hospital's IT infrastructure.

From Philips Healthcare 8 Oct 2010

Should Medicare consider cost-effectiveness when setting reimbursement rates?

Medicare reimbursement rates should be based on how cost effective the treatment is for a particular illness, according to a piece by two policy experts in the October edition of Health Affairs.

7 Oct 2010

Sirius Genomics signs second Contribution Agreement with NRC-IRAP

Sirius Genomics, a developer of companion diagnostics, announced today that it has signed its second Contribution Agreement with the National Research Council of Canada Industrial Research Assistance Program (NRC-IRAP).

5 Oct 2010

Chronic infection with S. maltophilia bacterium may impact cystic fibrosis progression: Study

Exacerbations in cystic fibrosis (CF) may be linked to chronic infection with a bacterium called Stenotrophomonas maltophilia, which was previously thought to simply colonize the CF lung. The finding that chronic infection with S. maltophilia is independently linked with an increased risk of exacerbations gives clinicians and researchers a new potential measure of the health status of CF patients, as well as a new potential target in fighting their disease.

4 Oct 2010

GSA urges treatment of sepsis as a medical emergency

The Global Sepsis Alliance (GSA) is urging healthcare providers, patients and policymakers worldwide to treat sepsis as a medical emergency. "Tens of millions of people die from sepsis each year, making it the likely leading cause of death worldwide. Sepsis kills regardless of age, ethnicity, location and access to care," said Konrad Reinhart, M.D., Chairman of the GSA and director of the Department of Anesthesiology and Intensive Care Medicine, University Hospital of the Friedrich Schiller, University of Jena, Germany.

1 Oct 2010

New legislation introduced to assess critical care services in the U.S.

Yesterday, House Energy and Commerce Committee Member Congresswoman Tammy Baldwin (D-WI) introduced legislation to assess and critical care health services in the United States.

1 Oct 2010

Alnylam Pharmaceuticals publishes ALN-RSV01 Phase IIa study results

Alnylam Pharmaceuticals, Inc. a leading RNAi therapeutics company announced today that it has published results in the American Journal of Respiratory and Critical Care Medicine from its double-blind, placebo-controlled, randomized Phase IIa study of ALN-RSV01 in lung transplant patients naturally infected with respiratory syncytial virus (RSV).

30 Sep 2010

Critical Care News and Research

Cipla launches generic Pirfenidone for IPF

Elsevier / MC Strategies partners with AORN to develop latest module for Perioperative Collection

Beryl Institute awards $1,000 grants to health care organizations

Study reveals sex hormones can influence structure and function of heart's right ventricle

NHLBI launches multicenter study of body cooling treatment in infants and children after cardiac arrest

Long term exposure to air pollution increases risk of severe COPD

Researchers explore impact of various factors on increasing rates of Clostridium difficile infection

OrSense's NBM 200MP non-invasive Hb measurement system more accurate than invasive POC devices

Abreu btt 700 System for continuous temperature monitoring launched at ASA Annual Meeting

Sirius collaborates with Golden Helix to advance diagnostic pipeline

Archimedes publishes results from FPNS Phase III clinical study for breakthrough cancer pain

Florida Governor issues Proclamation recognizing outstanding work of Healthcare Quality Professionals

IV ibuprofen effective in reducing fever in hospitalized patients

Royal Philips Electronics introduces IntelliVue MX800 patient monitoring system

Should Medicare consider cost-effectiveness when setting reimbursement rates?

Sirius Genomics signs second Contribution Agreement with NRC-IRAP

Chronic infection with S. maltophilia bacterium may impact cystic fibrosis progression: Study

GSA urges treatment of sepsis as a medical emergency

New legislation introduced to assess critical care services in the U.S.

Alnylam Pharmaceuticals publishes ALN-RSV01 Phase IIa study results

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Latest News